Sales of Johnson & Johnson's medical devices and diagnostics by franchise 2018-2021

Johnson & Johnson’s medical devices and diagnostics segment earned about 9.8 billion U.S. dollars through its surgery franchise specifically, in 2021. The orthopedics franchise was the segment’s second-largest field, generating roughly 8.6 billion U.S. dollars that year.

J&J’s revenue

In 2021, Johnson & Johnson’s global revenue amounted to some 93.8 billion U.S. dollars, which was an increase of around 11 billion U.S. dollars compared to the previous year. J&J has three major divisions: pharmaceutical, medical devices and diagnostics, and consumer. In 2021, an estimated 27 billion U.S. dollars were generated through the medical devices and diagnostics division. Roughly 16 percent of the company’s global revenue was generated through consumer health. Over the years, the multinational company with its various segments generated more than half of its revenues in the United States, making it the company’s main market. In 2021, roughly 23.6 billion U.S. dollars were generated in Europe, the company’s second most yielding region.